Deliver academic-level medicine and help keep patients close to home
With MolecularMatch, you can deliver academic-level medicine so patients stay within your network and close to home. The MolecularMatch platform provides evidence-based targeted therapy and immunotherapy recommendations as well as geo-located clinical trial matching for point of care and tumor boards. MMPower can be integrated with your EHR/EMR system for ease of access and ease of use.
The MolecularMatch difference: Tumor Genomics + Patient Clinical Details
Many factors affect a patient’s eligibility for a trial and likely response to a drug, so MolecularMatch considers more criteria than just tumor biomarkers. Our platform utilizes other clinical information from a patient’s medical records, such as comorbidities, mechanisms of resistance, performance status and Tumor Mutation Burden (TMB) to improve the quality of drug and trial matching. Our metrics indicate that surveillance of an EHR with MolecularMatch technology identifies up to 3-fold more patients potentially eligible for a clinical trial.
Match more patients to clinical trials
You can surveil your patient population to improve clinical trial enrollment at your institution by integrating MolecularMatch search capabilities into your EHR. Our studies have shown that surveillance of an EHR with MolecularMatch technology identifies up to 3-fold more patients potentially eligible for a clinical trial.
MolecularMatch provides a powerful resource for molecular pathologists. Identifying treatment options – particularly trials – is a time-consuming task. The MolecularMatch platform allows our team to efficiently match complex genomic test data to appropriate treatment options in much less time.
Christopher Corless, MD, PhD., Chief Medical Officer of the OHSU Knight Diagnostic Laboratories.